Related Experiment Video
Updated: Jun 21, 2026
Differentiation of Mouse Embryonic Stem Cells into Cortical Interneuron Precursors
Published on: December 3, 2017
The effect of interferon-beta on mouse neural progenitor cell survival and differentiation
Marek Hirsch1, Julia Knight, Mari Tobita
1Neurology Department, University of Vermont College of Medicine, Burlington, VT 05405, USA.
Abstract:
Interferon-beta (IFN-beta) is a mainstay therapy for relapse-remitting multiple sclerosis (MS). However, the direct effects of IFN-beta on the central nervous system (CNS) are not well understood. To determine whether IFN-beta has direct neuroprotective effects on CNS cells, we treated adult mouse neural progenitor cells (NPCs) in vitro with IFN-beta and examined the effects on proliferation, apoptosis, and differentiation. We found that mouse NPCs express high levels of IFNalpha/beta receptor (IFNAR). In response to IFN-beta treatment, no effect was observed on differentiation or proliferation. However, IFN-beta treated mouse NPCs demonstrated decreased apoptosis upon growth factor withdrawal. Pathway-specific polymerase chain reaction (PCR) arrays demonstrated that IFN-beta treatment upregulated the STAT 1 and 2 signaling pathway, as well as GFRA2, NOD1, Caspases 1 and 12, and TNFSF10. These results suggest that IFN-beta can directly affect NPC survival, possibly playing a neuroprotective role in the CNS by modulating neurotrophic factors.
Insights
Interferon-beta (IFN-beta) therapy for multiple sclerosis (MS) may directly protect brain cells. Studies show IFN-beta reduces neural progenitor cell death in the central nervous system (CNS).
Area of Science:
- Neuroscience
- Immunology
- Cell Biology
Background:
- Interferon-beta (IFN-beta) is a primary treatment for relapse-remitting multiple sclerosis (MS).
- The direct impact of IFN-beta on the central nervous system (CNS) remains unclear.
- Understanding these effects is crucial for optimizing MS therapy.
Purpose of the Study:
- To investigate the direct neuroprotective potential of IFN-beta on central nervous system (CNS) cells.
- To examine the effects of IFN-beta on neural progenitor cell (NPC) proliferation, apoptosis, and differentiation in vitro.
Main Methods:
- Adult mouse neural progenitor cells (NPCs) were cultured in vitro.
- NPCs were treated with IFN-beta.
- Cell proliferation, apoptosis, and differentiation were assessed.
- Pathway-specific polymerase chain reaction (PCR) arrays were used to analyze gene expression changes.
Main Results:
- Mouse NPCs express high levels of the interferon alpha/beta receptor (IFNAR).
- IFN-beta treatment did not alter NPC proliferation or differentiation.
- IFN-beta significantly decreased NPC apoptosis following growth factor withdrawal.
- Upregulation of STAT 1 and 2 signaling, GFRA2, NOD1, Caspases 1 and 12, and TNFSF10 was observed.
Conclusions:
- IFN-beta can directly influence neural progenitor cell survival.
- These findings suggest a potential neuroprotective role for IFN-beta in the CNS.
- IFN-beta may exert neuroprotection by modulating neurotrophic factors and related signaling pathways.
